SCHEMBL31590791

SCHEMBL31590791

CCN1CCCc2cc(CN)ccc21

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 13/20 0.67
GAA P10253 12/20 0.67
MAPT P10636 8/20 0.67
KDM4E B2RXH2 6/20 0.67
KMT2A Q03164 5/20 0.67
MEN1 O00255 4/20 0.67
LMNA P02545 2/20 0.67
CASP1 P29466 2/20 0.67
HTT P42858 2/20 0.67
TP53 P04637 2/20 0.67
CASP7 P55210 1/20 0.67
SMAD3 P84022 1/20 0.67
HSD17B10 Q99714 1/20 0.67
L3MBTL1 Q9Y468 1/20 0.67
HRH3 Q9Y5N1 2/20 0.49
RXFP1 Q9HBX9 2/20 0.45
RAD52 P43351 1/20 0.45
HPGD P15428 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
SMN1; SMN2 Q16637 6/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10784314 0.87 ALDH1A1 (0.52) ALDH1A1GAAMAPTKDM4EKMT2A
SCHEMBL8728819 0.84 ALDH1A1 (0.53) ALDH1A1GAAMAPTKDM4EKMT2A
SCHEMBL31020834 0.81 ALDH1A1 (0.59) ALDH1A1GAAMAPTKDM4EKMT2A
SCHEMBL1076966 0.81 ALDH1A1 (0.59) ALDH1A1GAAMAPTKDM4EKMT2A
SCHEMBL31020835 0.81 ALDH1A1 (0.59) ALDH1A1GAAMAPTKDM4EKMT2A
SCHEMBL10493943 0.81 ATAD2 (0.53) ALDH1A1GAAMAPTKDM4EKMT2A
SCHEMBL12956755 0.79 ALDH1A1 (0.59) ALDH1A1GAAMAPTKDM4EKMT2A
SCHEMBL23128840 0.78 HSD17B3 (0.52) ALDH1A1GAAMAPTKDM4EKMT2A
SCHEMBL8728886 0.78 HDAC1 (0.52) ALDH1A1GAAMAPTKDM4EKMT2A
SCHEMBL12656517 0.78 HDAC1 (0.53) ALDH1A1GAAMAPTKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260097029-A1 Tetrahydroquinoline Compounds As Antitumor Agents COSCONATI SANDRO (IT) 2026-04-09 US disclosed
CN-120051458-A Tetrahydroquinoline compounds as antitumor agents 桑德罗·科斯科纳蒂 2025-05-27 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260097029-A1 Tetrahydroquinoline Compounds As Antitumor Agents BCOR, MCL1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 ALDH1A1 1372/4885GAA 4067/4885MAPT 4765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.